Why Pairing Decentralized Trials With Pharmacies Results In Better Participant Access
Source: Medable
By Sanskriti Thakur, Chief Growth Officer at Medable

What is standing in the way between Americans and clinical trials?
There are123, 413 registered clinical trials in the United States1 with the majority of participants white males.1Consequently, we lack the diversity to make medicines that work for everybody. Perhaps even more troublesome, just 1% of cancer patients are enrolling in clinical trials as a first course of therapy after diagnosis.2 So, what is keeping them out?
A lack of access, awareness, and trust has caused an extreme lack of inclusivity in medical science.
VIEW THE ARTICLE!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Medable
This website uses cookies to ensure you get the best experience on our website. Learn more